Table 1.
Clinical and histopathological characteristics of the 362 patients
| Age (years) | |
| Median | 65 |
|
| |
| Range | 29–97 |
|
| |
| Stage, n (%) | |
| I | 242 (67) |
|
| |
| II | 43 (12) |
|
| |
| III | 55 (15) |
|
| |
| IV | 22 (6) |
|
| |
| Subtype, n (%) | |
| Endometrioid | 279 (77) |
|
| |
| CCC + serous | 80 (22) |
|
| |
| Others | 3 (1) |
|
| |
| Grade (FIGO), n (%) | |
| I | 160 (44) |
|
| |
| II | 72 (20) |
|
| |
| III | 130 (36) |
|
| |
| Grade (nuclear) | |
| 1 | 123 (34) |
|
| |
| 2 | 104 (29) |
|
| |
| 3 | 135 (37) |
|
| |
| Tumour size (mm) | |
| ≤20 | 86 (24) |
|
| |
| >20 | 276 (76) |
|
| |
| Depth of myometrial invasion (%) | |
| ≤50 | 239 (66) |
|
| |
| >50 | 123 (34) |
|
| |
| LVI | |
| No | 264 (73) |
|
| |
| Yes | 98 (27) |
|
| |
| Recurrence | |
| No | 264 (73) |
|
| |
| Yes | 98 (27) |
|
| |
| Skil | |
| Negative | 123 (34) |
|
| |
| Positive | 237 (66) |
|
| |
| DAB2 | |
| Negative | 303 (84) |
|
| |
| Positive | 57 (16) |
|
| |
| Status | |
| Alive with no evidence of disease | 279 (77) |
|
| |
| Alive with evidence of disease | 37 (10) |
|
| |
| Dead of disease | 29 (8) |
|
| |
| Dead with no evidence of disease | 10 (3) |
|
| |
| Others | 11 (3) |
CCC, clear cell carcinoma; FIGO, International Federation of Gynecology and Obstetrics; LVI, lymphovascular invasion.